Evidence map›Paper›PMID 39820322›Full record

ArticleThe Journal of experimental medicine2025

Cigarette smoke components modulate the MR1-MAIT axis.

Wael Awad, Jemma R Mayall, Weijun Xu, Matt D Johansen, Timothy Patton, Xin Yi Lim, Izabela Galvao, Lauren J Howson, Alexandra C Brown, Tatt Jhong Haw and 15 more

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Development of αβ and γδ T Cells in the Thymus and Methods of Analysis.International journal of molecular sciences · 2025
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Wael Awad *Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID 0000-0002-7597-2133
Jemma R Mayall *Immune Health Program, Hunter Medical Research Institute and The University of Newcastle , Newcastle, Australia.ORCID 0000-0002-0915-5020
Weijun Xu *ARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-3566-1082
Matt D JohansenCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0001-5553-5270
Timothy PattonDepartment of Immunology and Microbiology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-9642-7003
Xin Yi LimDepartment of Immunology and Microbiology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-9806-5894
Izabela GalvaoCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0002-9943-8349
Lauren J HowsonInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID 0000-0003-3522-4533
Alexandra C BrownImmune Health Program, Hunter Medical Research Institute and The University of Newcastle , Newcastle, Australia.ORCID 0000-0002-7492-9213
Tatt Jhong HawImmune Health Program, Hunter Medical Research Institute and The University of Newcastle , Newcastle, Australia.ORCID 0000-0003-2315-7089
Chantal DonovanImmune Health Program, Hunter Medical Research Institute and The University of Newcastle , Newcastle, Australia.ORCID 0000-0003-4558-329X
Shatarupa DasCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0003-3361-4546
Gesa J AlbersCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0002-8249-6956
Tsung-Yu PaiCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0002-4388-9861
Elinor HortleCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0001-9633-5638
Caitlin M GillisCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0001-9892-206X
Nicole G HansbroCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0002-2371-7990
Jay C HorvatImmune Health Program, Hunter Medical Research Institute and The University of Newcastle , Newcastle, Australia.ORCID 0000-0002-8526-0631
Ligong LiuARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-2693-1896
Jeffrey Y W MakARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-8011-4539
James McCluskeyDepartment of Immunology and Microbiology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0002-8597-815X
David P FairlieARC Centre of Excellence for Innovations in Peptide and Protein Science, Institute for Molecular Bioscience, University of Queensland , Brisbane, Australia.ORCID 0000-0002-7856-8566
Alexandra J CorbettDepartment of Immunology and Microbiology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.ORCID 0000-0003-1618-4337
Philip M HansbroCentre for Inflammation, Centenary Institute and University of Technology Sydney, Faculty of Science, School of Life Sciences , Sydney, Australia.ORCID 0000-0002-4741-3035
Jamie RossjohnInfection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.ORCID 0000-0002-2020-7522

Funding

Investigating the basis of MAIT cell antigen potencyR01AI148407 · NIAID · UNIVERSITY OF MELBOURNE · PI MCCLUSKEY, JAMES · 2020 to 2024
$2.7M
Australian Research Council DE220101491Cancer Council NSWCardiff UniversityNational Health and Medical Research Council of Australia 1125493NIAID NIH HHS R01 AI148407NIH HHS RO1 AI148407-01A1University of MelbourneUTS
6 · The paper itself

Abstract

Tobacco smoking is prevalent across the world and causes numerous diseases. Cigarette smoke (CS) compromises immunity, yet little is known of the components of CS that impact T cell function. MR1 is a ubiquitous molecule that presents bacterial metabolites to MAIT cells, which are highly abundant in the lungs. Using in silico, cellular, and biochemical approaches, we identified components of CS that bind MR1 and impact MR1 cell surface expression. Compounds, including nicotinaldehyde, phenylpropanoid, and benzaldehyde-related scaffolds, bound within the A' pocket of MR1. CS inhibited MAIT cell activation, ex vivo, via TCR-dependent and TCR-independent mechanisms. Chronic CS exposure altered MAIT cell phenotype and function and attenuated MAIT cell responses to influenza A virus infection in vivo. MR1-deficient mice were partially protected from the development of chronic obstructive pulmonary disease (COPD) features that were associated with CS exposure. Thus, CS can impair MAIT cell function by diverse mechanisms, and potentially contribute to infection susceptibility and disease exacerbations.

Indexed as

Cigarette SmokingHistocompatibility Antigens Class IMinor Histocompatibility AntigensMucosal-Associated Invariant T CellsSmokeAnimalsHumansInfluenza A virusLungLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutOrthomyxoviridae InfectionsPulmonary Disease, Chronic ObstructiveHistocompatibility Antigens Class IMinor Histocompatibility AntigensMR1 protein, humanMr1 protein, mouseSmoke

Identifiers

PMID39820322
PMCPMC11740918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.